Skip to content

Effect of Garcinia kola nuts on erectile dysfunctoion in Yaounde Central Hospital

A new treatment for mild erectile dysfunction: Garcinia kola nuts

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
PACTR
Registry ID
PACTR202310817915957
Enrollment
36
Registered
2023-10-26
Start date
2023-06-15
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urological and Genital Diseases

Interventions

Garcinia kola nuts

Sponsors

Ngameni Bathelemy
Lead Sponsor
Fouda Pierre Joseph
Collaborator

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: -All patients over 25 years of age who have had erectile dysfunction for at least 03 months a -All patients who have given their free and informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: -Any patient suffering from hypogonadism, prostate cancer or chronic kidney disease was not included in our study. - Any patient who had consumed Garcinia kola nuts or traditional pharmacopoeia in the two weeks prior to inclusion in the study. -Any patient with an unbalanced chronic condition during the study (grade 3 arterial hypertension, unbalanced diabetes: fasting blood glucose >1.8g/l in particular). - Severe intolerance to Garcinia kola nuts during the intervention -Withdrawal of consent to the study

Design outcomes

Primary

MeasureTime frame
improvement in erectile function (increase in erectile function score of at least 1 point).

Secondary

MeasureTime frame
The increase in satisfaction with sexual intercourse, orgasm, sexual desire, overall satisfaction and the overall IIEF15 score

Countries

Cameroon

Contacts

Public ContactLandry Oriole Mbouche

Faculty of Medicine and Biomedical Sciences of the University of Yaounde I

landrymbouche@gmail.com00237699881526

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026